COO Cooper Companies Inc.

CooperCompanies and Divisions Named One of Fortune’s Best Large Workplaces in Manufacturing and Production

CooperCompanies and Divisions Named One of Fortune’s Best Large Workplaces in Manufacturing and Production

CooperCompanies, CooperVision and CooperSurgical All Recognized by Fortune Magazine

SAN RAMON, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that the company, along with its CooperVision and CooperSurgical divisions has been named one of Fortune's Best Large Workplaces in Manufacturing and Production.

“Being included on Fortune’s Best Large Workplaces in Manufacturing and Production List is a testament to our outstanding employees,” said President and CEO Albert White. “For both CooperVision and CooperSurgical, our manufacturing and production teams are the backbone of the businesses, ensuring we produce, maintain and deliver our products around the globe.  In many ways, this award highlights the team effort across the organization from the products that our R+D teams invent and study, our M+A team’s purchase, our marketing teams promote, and our sales representatives sell.”

To determine the companies selected for this list, Fortune research partner Great Place to Work® analyzed responses from more than 160,000 employees at Great Place to Work-Certified™ organizations in the Manufacturing & Production industry. Employees responded to more than 60 survey questions anonymously rating their employers, assessing workplace culture, employee experience, and leadership behaviors.

According to White, being on this list is indicative of the emphasis the company puts on cooperation: “Partnership is a key element of our DNA – not just with our customers but also with our employees. During these difficult times we have heard from so many of our customers that they feel like we are an integral part of their team. For example, over the past months we had customers calling desperate for product and our teams worked night and day to get them what they needed. Our team knows that at the other end of every request is a woman making an important decision about her health or a person who needs to see clearly.”

About Great Place to Work

Great Place to Work® is a global authority on workplace culture. Since 1992, it has surveyed more than 100 million employees around the world and used those insights to define what makes a great workplace: trust. Great Place to Work helps organizations quantify their cultures and produce better business results by creating a high-trust work experience for all employees. Their benchmark data is used to recognize Great Place to Work-Certified companies and the Best Workplaces™ in the United States and more than 60 countries, including the 100 Best Companies to Work For® and World’s Best lists published annually in Fortune. To learn more, visit greatplacetowork.com.

About CooperCompanies

CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit .

Contact:

Kim Duncan

Vice President, Investor Relations and Risk Management

925-460-3663

EN
10/09/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cooper Companies Inc.

Cooper Companies Inc: 3 directors

A director at Cooper Companies Inc bought 2,000 shares at 82.500USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

 PRESS RELEASE

CooperCompanies Announces New Chair of the Board and Strategic Review

CooperCompanies Announces New Chair of the Board and Strategic Review SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today that its Board of Directors has appointed Colleen Jay to succeed current Chair Robert Weiss, effective January 2, 2026. Mr. Weiss will remain on the Board and stand for reelection for the upcoming year, marking his final term. The Company also announced a formal strategic review aimed at identifying opportunities to enhance long-term shareholder value. “Bob’s vision, industry knowledge, ...

 PRESS RELEASE

CooperCompanies Announces Fourth Quarter and Full Year 2025 Results

CooperCompanies Announces Fourth Quarter and Full Year 2025 Results SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today financial results for its fiscal fourth quarter and full year ended October 31, 2025. Fourth quarter 2025 revenue of $1,065.2 million, up 5%, or up 3% organically. Fiscal year 2025 revenue of $4.1 billion, up 5%, or up 4% organically.Fourth quarter 2025 GAAP diluted earnings per share (EPS) of $0.43, down 27%. Fiscal 2025 GAAP diluted EPS of $1.87, down 4%.Fourth quarter 2025 non-GA...

 PRESS RELEASE

CooperCompanies Announces Release Date for Fourth Quarter and Full Yea...

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025 SAN RAMON, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report fourth quarter and full year 2025 financial results on Thursday, December 4, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 2700541. A simultaneous audio webcast and subsequent replay c...

 PRESS RELEASE

CooperCompanies Announces Expanded Share Repurchase Program

CooperCompanies Announces Expanded Share Repurchase Program SAN RAMON, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today its Board of Directors has approved a $1 billion increase in the Company’s share repurchase program. The share repurchase program now totals $2 billion. “We are pleased to announce that our Board of Directors has authorized an increase to our share repurchase program,” said Al White, President and Chief Executive Officer. “This decision underscores the strength of our balance sheet and cas...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch